Grant H. Skrepnek, Ph.D., R.Ph.

Professor

Pharmacy Clinical & Admin Sci

Phone (405) 271-6878 x47105

Fax (4050 271-6430

Office CPB 214

Email grant-skrepnek@ouhsc.edu


Summary

I concentrate on health economics, policy, and outcomes research involving large-scale database investigations, decision analyses, clinical trials, and survey research. From a clinical stance, I focus on studying cost, quality, and access to care across various healthcare settings concerning oncology, cardiopulmonary disease, rare conditions, and comorbidities. I am engaged in advancing the methodological approaches used within assessments of health technology, including the development of novel statistical procedures to evaluate health and economic data.



Research

Dr. Skrepnek concentrates on health economics, policy, and outcomes research involving large-scale database investigations, decision analyses, clinical trials, and survey research. From a clinical stance, Dr. Skrepnek focuses on studying cost, quality, and access to care across various healthcare settings concerning oncology, cardiopulmonary disease, rare conditions, and comorbidities. He is engaged in advancing the methodological approaches used within assessments of health technology, including the development of novel statistical procedures to evaluate health and economic data.




Publications & Presentations

    111. Skrepnek G H, Ballard E E. Cost-efficacy of imatinib versus allogeneic bone marrow transplantation with a matched unrelated donor in the treatment of chronic myelogenous leukemia: a decision-analytic approach. Pharmacotherapy. 2005; 25 : 325-34

    112. Skrepnek G H, Armstrong E P, Malone D C, Ramachandran S. An economic and outcomes assessment of first-line monotherapy in the treatment of community-acquired pneumonia within managed care. Current medical research and opinion. 2005; 21 : 261-70

    113. Skrepnek G H, Skrepnek S V. An assessment of therapeutic regimens in the treatment of acute exacerbations in chronic obstructive pulmonary disease and asthma. The American journal of managed care. 2004; 10 : S139-52

    114. Skrepnek G H, Skrepnek S V. Epidemiology, clinical and economic burden, and natural history of chronic obstructive pulmonary disease and asthma. The American journal of managed care. 2004; 10 : S129-38

    115. Skrepnek G H. Accounting- versus economic-based rates of return: implications for profitability measures in the pharmaceutical industry. Clinical therapeutics. 2004; 26 : 155-74




Grants

<< 1 2 3 4 >>
    6. C1097002 - Improving evidence-based antibiotic use for treatment of infections commonly seen in long term . Federal Non-NIH. Start Date: 2019. End Date: 2020.

    7. C2010628 - Drug Utilization Review 2020 [Service Award]. State Agency. Start Date: 2019. End Date: 2020.

    8. C2015602 - 1815 Medication Therapy Management, Tele-MTM. Non-federal. Start Date: 2019. End Date: 2020.

    9. C7069901 - MTM Drug Utilization Review. Non-federal. Start Date: 2019. End Date: 2020.

    10. C7070101 - Study of Oklahoma Medicaid Assessing Outcomes Associated with Long-Acting Injectable Antipsychotics. Non-federal. Start Date: 2019. End Date: 2020.

<< 1 2 3 4 >>



Awards and Honors


no results

Education


no results

Administrative Assignments

                                                

    1. Role: Director. Scope: Department. Date: 2019.

                                                

    2. Role: Director. Scope: Department. Description: Interim Director & Director of Academic Research. Date: 2019.